Tumorigenesis and the angiogenic switch

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.     

Fucosyl glycopeptide profiles of keratinocytes from various epithelial tissues of the rabbit in relation to differentiation in vivo and in vitro

Keratinocytes have been isolated from rabbit cornea, esophagus, and skin by trypsinization. The freshly isolated cells differed in their morphology, growth characteristics in culture, transglutaminase activity (a marker for differentiation), and the composition of glycoprotein-derived fucopeptides. A clear relationship has been shown between the proportion of low-molecular-weight fucopeptides and the pattern of keratinization, being minimal in cornea and maximal in skin. Comparison with earlier literature suggests that this relationship may be a general feature of epithelial tissue. After several passages in culture, all differences between the three cell types disappeared. The unusual elution pattern of the fucopeptides on gel filtration suggests the possibility of a block at an early stage of glycoprotein synthesis under culture conditions.     

A unique phospholipase A2 in human epidermis: its physiologic function and its level in certain dermatoses

It is now well established that epidermis, like many other tissues, contains a phospholipase A2 that is responsible for the initiation of the arachidonic acid cascade. Here we report that human epidermis also contains a second, quite distinct enzyme of the phospholipase A2 group, which is unique in its extreme activity against phospholipids in true solution. It also differs from the classic cutaneous enzyme in that (a) its activity is not reduced by pretreatment of the skin with corticosteroids in vivo nor by treatment of the epidermal homogenate with alkaline phosphatase in vitro, and (b) its activity is reduced, rather than increased, in the lesions of inflammatory diseases such as psoriasis. The enzyme seems to occur mainly in fully differentiated keratinocytes, its level being low in the basal cell layer of epidermis and in keratinocytes cultured in vitro. On the basis of these observations, we suggest that this new phospholipase A2 is responsible for the degradation of phospholipids that accompanies the terminal keratinization process.